Literature DB >> 6272420

The value, limitations, and applications of nuclear dacryocystography.

M Brown, T A El Gammal, M N Luxenberg, C Eubig.   

Abstract

Nuclear dacryocystography is simple, relatively harmless method of evaluating patients suspected of having abnormalities of the nasolacrimal drainage system. A group of normal saline containing approximately 100 muCi of 99mTc-pertechnetate is placed on the conjunctiva near the lateral canthus, and serial scintigrams are obtained as the pertechnetate flows along the tear strips, through the nasolacrimal drainage system, into the nasal fossa. By using a pinhole collimator with a very small aperture (1mm), the canaliculi, the nasolacrimal sac, and the nasolacrimal duct are readily visualized. When flow is impaired, the site of obstruction can often be identified. Contrast dacryocystography provides similar information but requires the injection of contrast material directly into a canaliculus. Nuclear dacryocystography provides good functional assessment of nasolacrimal drainage but has serious shortcomings in defining pathologic anatomy. Contrast dacryocystography outlines the anatomy well but often misses minor obstructions. The two studies are complementary and together provide an effective means of evaluating the nasolacrimal drainage system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272420     DOI: 10.1016/s0001-2998(81)80022-0

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  2 in total

1.  Evaluation of Patients for Endoscopic DCR: Sac Syringing and Radionuclide Scintigraphy.

Authors:  Col Uma Patnaik; Maj Atul Gupta; Brig Ajith Nilakantan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-16

2.  Comparison of dacryocystography and lacrimal scintigraphy in the diagnosis of functional nasolacrimal duct obstruction.

Authors:  M J Wearne; J Pitts; J Frank; G E Rose
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.